A rare clinical variant of Guillain-Barre syndrome, known as Miller Fisher syndrome (MFS), is an acute immune-mediated demyelinating polyneuropathy classically presenting as a triad of ataxia, areflexia, and ophthalmoplegia. This disorder is typically associated with multiple cranial nerve dysfunction and occasionally with distal paresthesia and motor weakness. MFS is thought to be preceded by an upper respiratory tract or gastrointestinal infection resulting in molecular mimicry and an aberrant autoimmune response specially against gangliosides. Diagnosis of MFS is made based of clinical presentation, cerebral spinal fluid (CSF) analysis, and electromyography and serological evaluation. Understanding the clinical signs and progression of this disease can aid in the early recognition and management of these patients.